Welcome!

Web 2.0 Authors: Roger Strukhoff, Elizabeth White, Kevin Benedict, Liz McMillan, Esmeralda Swartz

News Feed Item

PHT Corporation Reports Record Breaking 2nd Quarter as Pharma Industry Champions Patient-Driven eData Systems in Clinical Research

PHT Corporation is experiencing exponential growth in 2014 with a 124% increase in demand for products and services in the second quarter over the same period in 2013. PHT is the leading provider of technologies used to collect patient-driven eData for clinical research. Sponsors and CROs use PHT products and services to deploy clinical outcome assessments on the web, smartphones and tablets.

The PHT eCOA System was chosen by 14 pharmaceutical and biotechnology companies including 3 new clients to collect compliant, patient-driven eData for 25+ clinical research programs in over 7 therapeutic areas. Sales were both direct to customer and through CRO partnerships. Top therapeutic areas included CNS, endocrinology, respiratory and oncology.

PHT President and CEO Philip Lee said, “PHT has been actively preparing for this growth in new business by increasing our capacity, tools and infrastructure. The investment in the PHT Product Suite to use the latest devices including the Nexus 5, Dell Venue with embedded 3G and 4G connectivity, and support for the BYOD models is paying dividends through added system flexibility and ease of use by patients, sites and sponsors.”

The FDA’s growing focus on patient reported outcomes (PROs) including symptom data in therapies like oncology was illustrated by the recent rejection of a new drug application for a malignant melanoma drug due to insufficient symptom-level data. http://www.pharmamedtechbi.com/publications/rpm-report/first-take/2014/4/provectus-breakthrough-denial-is-symptom-of-a-different-breakthrough-at-fda

Additional PHT Q2 highlights included:

PHT Vice President of Marketing and Product Management Sheila Rocchio, MBA, commented, “The PHT Product Suite helps clinical trial sponsors support more patient-centric trials. The Medication Module is helping sponsors and patients more accurately track and manage rescue and concomitant medication in real time, resulting in a better trial experience for both patients and sites.” Sheila discusses how PHT’s patient suite promotes patient healthcare, and how an app for every trial enables patient-centric research: http://bit.ly/PatientSuite

About PHT Corporation

PHT Corporation is the eClinical innovator leading the adoption of patient-driven mobile apps for better clinical research. The PHT electronic clinical outcome assessment (eCOA) system collects and reports secure real-time patient data from the latest mobile devices. PHT scientific, regulatory and technological expertise combined with quality outcomes data enables clients to make research decisions with confidence. Sponsors and CROs have leveraged the PHT Patient Suite in 650+ trials resulting in 16+ regulatory approvals. Visit phtcorp.com. Join the PRO & eCOA Congress LinkedIn Community. Follow PHT on LinkedIn, Facebook, Twitter, Google+ and YouTube.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.